Pacira Sells iovera to Zimmer Biomet in Up to $140M Deal to Focus on Drug Growth

Event Summary

On July 1, Pacira (PCRX) sold its iovera franchise to Zimmer Biomet (ZBH) in a deal worth up to $140M to sharpen its focus on biopharmaceutical growth. On July 2, U.S. Physical Therapy purchased a majority stake in a physical therapy practice. Additionally, Orthofix Medical shares rose following a decision by the Centers for Medicare & Medicaid Services (CMS) to reverse its stance on non-invasive bone growth stimulators.